349 related articles for article (PubMed ID: 10206574)
21. Antibody reactions with retina and cancer-associated antigens in 10 patients with cancer-associated retinopathy.
Thirkill CE; Keltner JL; Tyler NK; Roth AM
Arch Ophthalmol; 1993 Jul; 111(7):931-7. PubMed ID: 8392327
[TBL] [Abstract][Full Text] [Related]
22. Antirecoverin autoantibodies in the patient with non-small cell lung cancer but without cancer-associated retinopathy.
Savchenko MS; Bazhin AV; Shifrina ON; Demoura SA; Kogan EA; Chuchalin AG; Philippov PP
Lung Cancer; 2003 Sep; 41(3):363-7. PubMed ID: 12928127
[TBL] [Abstract][Full Text] [Related]
23. Cancer-associated retinopathy syndrome: a case of small cell lung cancer expressing recoverin immunoreactivity.
Matsubara S; Yamaji Y; Fujita T; Kanayama T; Yamadori I; Sato M; Fujita J; Shiotani T; Takahara J
Lung Cancer; 1996 Jun; 14(2-3):265-71. PubMed ID: 8794409
[TBL] [Abstract][Full Text] [Related]
24. The cancer-associated retinopathy antigen is a recoverin-like protein.
Thirkill CE; Tait RC; Tyler NK; Roth AM; Keltner JL
Invest Ophthalmol Vis Sci; 1992 Sep; 33(10):2768-72. PubMed ID: 1388144
[TBL] [Abstract][Full Text] [Related]
25. Apoptotic retinal cell death induced by antirecoverin autoantibodies of cancer-associated retinopathy.
Adamus G; Machnicki M; Seigel GM
Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):283-91. PubMed ID: 9040460
[TBL] [Abstract][Full Text] [Related]
26. Cancer-associated retinopathy during treatment for small-cell lung carcinoma.
Kashiwabara K; Nakamura H; Kishi K; Yagyu H; Sarashina G; Kobayashi K; Matsuoka T
Intern Med; 1999 Jul; 38(7):597-601. PubMed ID: 10435368
[TBL] [Abstract][Full Text] [Related]
27. Cancer-associated retinopathy.
Goldstein SM; Syed NA; Milam AH; Maguire AM; Lawton TJ; Nichols CW
Arch Ophthalmol; 1999 Dec; 117(12):1641-5. PubMed ID: 10604671
[TBL] [Abstract][Full Text] [Related]
28. Paraneoplastic cone dysfunction: an unusual visual remote effect of cancer.
Jacobson DM; Thirkill CE
Arch Ophthalmol; 1995 Dec; 113(12):1580-2. PubMed ID: 7487640
[No Abstract] [Full Text] [Related]
29. Antibodies to recoverin induce apoptosis of photoreceptor and bipolar cells in vivo.
Adamus G; Machnicki M; Elerding H; Sugden B; Blocker YS; Fox DA
J Autoimmun; 1998 Oct; 11(5):523-33. PubMed ID: 9802939
[TBL] [Abstract][Full Text] [Related]
30. Clinical and immunologic aspects of cancer-associated retinopathy.
Ohguro H; Yokoi Y; Ohguro I; Mamiya K; Ishikawa F; Yamazaki H; Metoki T; Takano Y; Ito T; Nakazawa M
Am J Ophthalmol; 2004 Jun; 137(6):1117-9. PubMed ID: 15183799
[TBL] [Abstract][Full Text] [Related]
31. Autoimmune retinopathy: patients with antirecoverin immunoreactivity and panretinal degeneration.
Heckenlively JR; Fawzi AA; Oversier J; Jordan BL; Aptsiauri N
Arch Ophthalmol; 2000 Nov; 118(11):1525-33. PubMed ID: 11074809
[TBL] [Abstract][Full Text] [Related]
32. Cancer-associated retinopathy in patients with breast carcinoma.
Misiuk-Hojło M; Ejma M; Gorczyca WA; Szymaniec S; Witkowska D; Fortuna W; Miedzybrodzki R; Rogozińska-Szczepka J; Bartnik W
Arch Immunol Ther Exp (Warsz); 2007; 55(4):261-5. PubMed ID: 17659379
[TBL] [Abstract][Full Text] [Related]
33. Retinal degeneration under the effect of antibodies to recoverin.
Bazhin AV; Slepova OS; Tikhomirova NK
Bull Exp Biol Med; 2001 Apr; 131(4):350-2. PubMed ID: 11550024
[TBL] [Abstract][Full Text] [Related]
34. Identification of human antitumor cytotoxic T lymphocytes epitopes of recoverin, a cancer-associated retinopathy antigen, possibly related with a better prognosis in a paraneoplastic syndrome.
Maeda A; Ohguro H; Nabeta Y; Hirohashi Y; Sahara H; Maeda T; Wada Y; Sato T; Yun C; Nishimura Y; Torigoe T; Kuroki Y; Sato N
Eur J Immunol; 2001 Feb; 31(2):563-72. PubMed ID: 11180121
[TBL] [Abstract][Full Text] [Related]
35. Autoantibodies against retinal proteins in paraneoplastic and autoimmune retinopathy.
Adamus G; Ren G; Weleber RG
BMC Ophthalmol; 2004 Jun; 4():5. PubMed ID: 15180904
[TBL] [Abstract][Full Text] [Related]
36. Recoverin and Hsc 70 are found as autoantigens in patients with cancer-associated retinopathy.
Ohguro H; Ogawa K; Nakagawa T
Invest Ophthalmol Vis Sci; 1999 Jan; 40(1):82-9. PubMed ID: 9888430
[TBL] [Abstract][Full Text] [Related]
37. Pathological roles of recoverin in cancer-associated retinopathy.
Ohguro H; Nakazawa M
Adv Exp Med Biol; 2002; 514():109-24. PubMed ID: 12596918
[TBL] [Abstract][Full Text] [Related]
38. Invasive thymoma with paraneoplastic retinopathy.
Yamada G; Ohguro H; Aketa K; Itoh T; Shijubo N; Takahashi H; Fujiwara O; Satoh M; Ohtsuka K; Abe S
Hum Pathol; 2003 Jul; 34(7):717-9. PubMed ID: 12874770
[TBL] [Abstract][Full Text] [Related]
39. Antirecoverin antibody in the aqueous humor of a patient with cancer-associated retinopathy.
Ohguro H; Maruyama I; Nakazawa M; Oohira A
Am J Ophthalmol; 2002 Oct; 134(4):605-7. PubMed ID: 12383822
[TBL] [Abstract][Full Text] [Related]
40. Recoverin, a photoreceptor-specific calcium-binding protein, is expressed by the tumor of a patient with cancer-associated retinopathy.
Polans AS; Witkowska D; Haley TL; Amundson D; Baizer L; Adamus G
Proc Natl Acad Sci U S A; 1995 Sep; 92(20):9176-80. PubMed ID: 7568096
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
